Venter discusses the future of genomics

03/12/2013 | Medscape (free registration)

The next step in the genomics revolution is to incorporate genomics into drug testing and development, says genomics pioneer J. Craig Venter. As genome sequencing has gotten faster and cheaper, it has also gotten less accurate, and a diploid genome map is necessary to pinpoint the genetics associated with a given disease, Venter said. His new institute on the University of California, San Diego, campus will focus on synthetic and environmental genomics research as well as the relationship between microbiomes and disease.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA